Related websites>
-
China deepens comprehensive reform to strengthen drug, medical device regulation
China has issued a guideline on comprehensively deepening the reform of regulation of drugs and medical devices to promote the high-quality development of the pharmaceutical industry.
-
1st stem cell therapy, new HIV drug approved
China's top drug regulator has recently approved the nation's first stem cell therapy to treat a type of complication associated with bone marrow transplant, as well as a novel HIV drug that only requires two shots yearly.
-
Xu Jinghe attends Global Harmonization Working Party annual meeting
Xu Jinghe, deputy commissioner of China's National Medical Products Administration, attended the 28th annual meeting of the Global Harmonization Working Party (GHWP) and the 28th GHWP Technical Committee Meeting, which were held in Kuala Lumpur, capital of Malaysia, from Dec 9 to 12.
